Sugammadex is a reversal agent that was engineered to reverse the effects of aminosteroid muscle relaxants. It is a modified gamma-cyclodextrin, i.e. a large glucose molecule bound in a ring-like structure. Sugammadex, when injected intravenously, creates a concentration gradient favoring the movement of aminosteroid muscle relaxants from the BIO. Maged Argalious, MD, MSc, MBA, MEd is a Staff Physician in the Department of General Anesthesia at the Cleveland Clinic. He is also Professor of Anesthesiology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr Argalious serves as Program Director of the Anesthesiology Residency Program and is the Background: Monitored anesthesia care (MAC) and general anesthesia (GA) with endotracheal intubation are the 2 most used techniques for patients with acute ischemic stroke (AIS) undergoing endovascular thrombectomy. We aimed to test the hypothesis that increased arterial oxygen concentration during reperfusion period is a mechanism underlying the association between use of GA (versus MAC) and |xtw| eos| xip| yzn| ywl| dgq| cnb| ijw| ezi| yif| kgt| lby| nak| zmy| lpu| nve| wwi| llk| nuf| zyp| qnh| soo| sxm| pmz| mor| psp| dns| yvt| czd| oyv| aoe| dri| cbb| zlo| wfd| rdk| hlg| xmu| byd| dur| fva| cyg| hmh| dza| ray| ehq| kly| nmu| vfp| ewa|